Incidence and Risk Factors for Necessitating Cerebrospinal Fluid Diversion Following Medulloblastoma Surgery in Children

Pediatr Neurol. 2023 Sep:146:95-102. doi: 10.1016/j.pediatrneurol.2023.06.016. Epub 2023 Jun 24.

Abstract

Background: There are insufficient data on pediatric patients with medulloblastoma who require cerebrospinal fluid (CSF) diversion following resection. Therefore, this study aimed to determine the incidence and the characteristics associated with it in this subset of patients.

Methods: We conducted a single-center, retrospective, observational cohort study of patients aged 18 years or less who underwent medulloblastoma resection at our department between 2010 and 2021. The primary outcome was the incidence of CSF diversion surgery required after resection. Participant demographics, tumor biology, and interventions were analyzed using univariate- and multivariate-adjusted models.

Results: Of the 183 patients admitted to our department, 131 (71.6%) participated in this study. The incidence of permanent CSF diversion was 26.0% (95% confidence interval [CI]: 18.7 to 34.3). Factors independently associated with requirement of permanent CSF diversion were medulloblastoma volume >46.4 cm3 (odds ratio [OR]: 2.919, 95% CI: 1.191 to 7.156) and CSF channel invasion (OR: 2.849, 95% CI: 1.142 to 7.102). The duration of manifestation may be a covariate of tumor volume with increased risk of requirement for permanent CSF diversion (OR: 1.006, 95% CI: 1.000 to 1.013), and tumor volume may be a predictor in patients who underwent subtotal resection (OR: 4.900, 95% CI: 0.992 to 24.208, P = 0.05). Finally, patients who required permanent CSF diversion were divided according to medulloblastoma molecular subgroups, and no significant differences were found.

Conclusion: We report major predictive factors for permanent CSF diversion surgery in patients with medulloblastoma. Our study suggests that the presence of postresection hydrocephalus is not high enough to warrant permanent, prophylactic CSF diversion in all patients.

Keywords: Hydrocephalus; Medulloblastoma; Molecular subgroup; Shunt.

Publication types

  • Observational Study

MeSH terms

  • Cerebellar Neoplasms* / complications
  • Cerebellar Neoplasms* / epidemiology
  • Cerebellar Neoplasms* / surgery
  • Child
  • Humans
  • Hydrocephalus* / etiology
  • Incidence
  • Medulloblastoma* / complications
  • Medulloblastoma* / epidemiology
  • Medulloblastoma* / surgery
  • Retrospective Studies
  • Risk Factors